Study | Patients, N | Type of cancer | Inclusion criteria | ≥1 ED visit (%) |
Ersek et al 42 | 847 | NSCLC | Any | 66.90 |
Falchook et al 32 | 12 765 | Lung | Patient <65 years | 1.8 |
Wu et al 23 | 49 920 | All | Palliative chemotherapy <6 months | 34 |
Any chemotherapy | 13.7 | |||
Henson et al 43 | 681 | All | Any | 29.70 |
Wright et al 14 | 1146 | All | Any | 7.90 |
Wang et al 52 | 82 242 | All | 2005 | 34 |
2009 | 32.90 | |||
Choi et al 30 | 263 | All | 2002 | 22.8 |
2012 | 74.8 | |||
Cheung et al 31 | 107 253 | All | Any | 14.7 |
Amano et al 58 | 266 | All | Early palliative care | 11 |
SOC | 4.70 | |||
Mack et al 46 | 1231 | NSCLC and colorectal | Any | 40 |
Ho et al 37 | 22 761 | All | 1993 | 8.60 |
2003 | 10.50 | |||
Gonsalves et al 44 | 200 | All | 2002 | 6 |
2008 | 9 | |||
Keating et al 47 | 5826 | NSCLC and colorectal | VHA cohort | 13.10 |
SEER cohort | 14.70 | |||
Tang et al 28 | 242 530 | All | Trend 2000–2006 | 18.3 |
Temel et al 36 | 46 | NSCLC | Integrated palliative care | 10 |
Barbera et al 34 | 5855 | All | Any | 32.20 |
Earle et al 16 | 28 777 | All | 1993 | 7.20 |
1996 | 9.20 |
ED, emergency department; NSCLC, non-small cell lung cancer; SEER, Surveillance, Epidemiology and End Results; SOC, standard of care; VHA, Veterans Health Administration.